Regis Lhomme, general manager of Amgen Romania, was named president of the Romanian Association of International Drugs Manufacturers (ARPIM). He is replacing Franz Zinsberger, general manager Boehringer Ingelheim, who held this position starting April this year. Also, the ARPIM General Meeting held on September 29 decided that Efthymios Papataxiarchis, the General Manager of Johnson & Johnson, will be the Association's Vice-president.

Regis Lhomme took over as head of the Romanian branch of the biotechnology company Amgen in October 2009.

ARPIM supports the interests of 28 international pharmaceutical companies present in Romania. Together, these companies cover about 70 percent of the Romanian pharmaceutical market.

Irina Popescu, irina.popescu@romania-insider.com

(photo source: Sxc.hu)